Treatment for the President could include experimental drugs that have not yet received emergency authorization from the US Food and Drug Administration and are unavailable to the general public, according to a source familiar with the White House Medical Unit.
Instead of enrolling in a trial or going through a compassionate use program, the source noted that the WHMU would likely work to obtain those drugs through already-established relationships.
These drugs could be available to the President, but that does not mean they will be necessary.
Current treatments for Covid-19 are limited. There are three that have received emergency use authorization (EUA) from the FDA: the antiviral remdesivir, the steroid dexamethasone and convalescent plasma, which is donated by people who recovered from the coronavirus.
According to the FDA, an EUA allows “unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions” from chemical, biological, radiological and nuclear threat agents “when there are no adequate, approved, and available alternatives.”